[go: up one dir, main page]

FI864555A7 - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-benzyl-1-(2h)-ftalazinonderivat. - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-benzyl-1-(2h)-ftalazinonderivat.

Info

Publication number
FI864555A7
FI864555A7 FI864555A FI864555A FI864555A7 FI 864555 A7 FI864555 A7 FI 864555A7 FI 864555 A FI864555 A FI 864555A FI 864555 A FI864555 A FI 864555A FI 864555 A7 FI864555 A7 FI 864555A7
Authority
FI
Finland
Prior art keywords
phthalazinonderivat
benzyl
foerfarande foer
foer framstaellning
terapeutiskt anvaendbara
Prior art date
Application number
FI864555A
Other languages
English (en)
Other versions
FI88504C (fi
FI88504B (fi
FI864555A0 (fi
Inventor
Juergen Engel
Gerhard Scheffler
Original Assignee
Asta Werke Ag Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Werke Ag Chem Fab filed Critical Asta Werke Ag Chem Fab
Publication of FI864555A0 publication Critical patent/FI864555A0/fi
Publication of FI864555A7 publication Critical patent/FI864555A7/fi
Application granted granted Critical
Publication of FI88504B publication Critical patent/FI88504B/fi
Publication of FI88504C publication Critical patent/FI88504C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI864555A 1985-11-11 1986-11-10 Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-benzyl-1-(2H)-ftalazinonderivat FI88504C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3539873 1985-11-11
DE3539873 1985-11-11

Publications (4)

Publication Number Publication Date
FI864555A0 FI864555A0 (fi) 1986-11-10
FI864555A7 true FI864555A7 (fi) 1987-05-12
FI88504B FI88504B (fi) 1993-02-15
FI88504C FI88504C (fi) 1993-05-25

Family

ID=6285623

Family Applications (1)

Application Number Title Priority Date Filing Date
FI864555A FI88504C (fi) 1985-11-11 1986-11-10 Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-benzyl-1-(2H)-ftalazinonderivat

Country Status (20)

Country Link
US (1) US4841047A (fi)
EP (1) EP0222191B1 (fi)
JP (1) JPH0780871B2 (fi)
CN (1) CN86107627A (fi)
AT (1) ATE60598T1 (fi)
AU (1) AU593593B2 (fi)
CA (1) CA1295613C (fi)
DD (1) DD263058A5 (fi)
DE (1) DE3677322D1 (fi)
DK (1) DK172076B1 (fi)
ES (1) ES2031813T3 (fi)
FI (1) FI88504C (fi)
GR (1) GR3001412T3 (fi)
HU (1) HU196793B (fi)
IE (1) IE59056B1 (fi)
IL (1) IL80560A0 (fi)
NO (1) NO864474L (fi)
PT (1) PT83713B (fi)
SU (1) SU1454251A3 (fi)
ZA (1) ZA868531B (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU609210B2 (en) * 1987-11-13 1991-04-26 Viatris Gmbh & Co. Kg Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
FR2643373B1 (fr) * 1989-01-10 1993-12-31 Adir Cie Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
ATE107643T1 (de) * 1989-05-05 1994-07-15 Asta Medica Ag Salze des azelastins mit verbesserter löslichkeit.
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
DE4207234A1 (de) * 1992-03-07 1993-09-09 Asta Medica Ag Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung
EP0561166A1 (de) * 1992-03-17 1993-09-22 ASTA Medica Aktiengesellschaft Dosieraerosole enthaltend den Wirkstoff D-18024 und verwandte Strukturen
CZ199593A3 (en) * 1992-10-02 1994-04-13 Asta Medica Ag Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr)
US7151102B2 (en) * 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
AU2003229953A1 (en) * 2002-04-30 2003-11-17 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7449464B2 (en) * 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
PT2486942T (pt) 2004-11-24 2019-01-18 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
GB0428111D0 (en) * 2004-12-22 2005-01-26 Kudos Pharm Ltd Pthalazinone derivatives
GB0521373D0 (en) * 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
KR20090007604A (ko) * 2006-04-20 2009-01-19 글락소 그룹 리미티드 히스타민 ｈ１ 및 ｈ３ 길항제로서의 2―치환된 4―벤질프탈라지논 유도체
EP2041087A1 (en) * 2006-06-15 2009-04-01 Kudos Pharmaceuticals Limited 2 -oxybenzamide derivatives as parp inhibitors
JP2009539962A (ja) * 2006-06-15 2009-11-19 クドス ファーマシューティカルズ リミテッド Ｐａｒｐ阻害剤としての２−オキシヘテロアリールアミド誘導体
WO2007144652A2 (en) * 2006-06-15 2007-12-21 Kudos Pharmaceuticals Limited Parp inhibitors
UY30639A1 (es) * 2006-10-17 2008-05-31 Kudos Pharm Ltd Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
US20100184770A1 (en) * 2006-12-20 2010-07-22 Glaxo Group Limited Compounds
US20080280910A1 (en) * 2007-03-22 2008-11-13 Keith Allan Menear Phthalazinone derivatives
TW200900396A (en) * 2007-04-10 2009-01-01 Kudos Pharm Ltd Phthalazinone derivatives
US20090023727A1 (en) * 2007-07-05 2009-01-22 Muhammad Hashim Javaid Phthalazinone derivatives
AU2008299721A1 (en) 2007-09-14 2009-03-19 Astrazeneca Ab Phthalazinone derivatives
US20100216799A1 (en) * 2007-10-11 2010-08-26 Glaxo Group Limited Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists
WO2009050469A1 (en) * 2007-10-17 2009-04-23 Kudos Pharmaceuticals Limited 4- [3- (4-cyclopropanecarbonyl-piperazine-i-carbonyl) -4 -fluoro-benzyl] -2h-phthalaz in-1-one
AR070221A1 (es) 2008-01-23 2010-03-25 Astrazeneca Ab Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas.
PL2346495T5 (pl) 2008-10-07 2024-06-10 Kudos Pharmaceuticals Limited Preparat farmaceutyczny 514
WO2011007145A1 (en) * 2009-07-15 2011-01-20 Astrazeneca Ab Phthalazinone compound as parp inhibitor
CN113956239A (zh) * 2021-10-28 2022-01-21 昆明源瑞制药有限公司 一种盐酸氮卓斯汀及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017411A (en) * 1962-01-16 New substituted phthalazones and proc-
DE2114884A1 (de) * 1971-03-27 1972-10-12 Cassella Farbwerke Mainkur Ag, 6000 Frankfurt Basisch substituierte Derivate des 1(2H)-Phthalazinons
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
EP0174464B1 (de) * 1984-09-14 1990-01-03 ASTA Pharma AG Substituierte Benzylphthalazinon-Derivate
DE3530793A1 (de) * 1984-09-14 1986-03-27 Asta-Werke Ag Chemische Fabrik, 4800 Bielefeld Substituierte benzylphthalazinon-derivate

Also Published As

Publication number Publication date
DK172076B1 (da) 1997-10-13
AU593593B2 (en) 1990-02-15
EP0222191A1 (de) 1987-05-20
FI88504C (fi) 1993-05-25
ATE60598T1 (de) 1991-02-15
JPS62114987A (ja) 1987-05-26
PT83713B (pt) 1989-06-30
FI88504B (fi) 1993-02-15
DE3677322D1 (de) 1991-03-07
ES2031813T3 (es) 1993-01-01
SU1454251A3 (ru) 1989-01-23
JPH0780871B2 (ja) 1995-08-30
US4841047A (en) 1989-06-20
PT83713A (de) 1986-12-01
DD263058A5 (de) 1988-12-21
DK536486D0 (da) 1986-11-10
IL80560A0 (en) 1987-02-27
CN86107627A (zh) 1987-07-15
EP0222191B1 (de) 1991-01-30
DK536486A (da) 1987-05-12
AU6498286A (en) 1987-05-14
CA1295613C (en) 1992-02-11
IE59056B1 (en) 1993-12-15
NO864474D0 (no) 1986-11-10
HU196793B (en) 1989-01-30
ZA868531B (en) 1987-07-29
FI864555A0 (fi) 1986-11-10
NO864474L (no) 1987-05-12
HUT42084A (en) 1987-06-29
GR3001412T3 (en) 1992-09-25
IE862960L (en) 1987-05-11

Similar Documents

Publication Publication Date Title
FI864555A7 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-benzyl-1-(2h)-ftalazinonderivat.
FI855118L (fi) Foerfarande foer framstaellning av nya peptid-aldehyder.
FI852515L (fi) Foerfarande foer framstaellning av nya gangliosidderivat.
FI80883B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensotiazol- och bensotiofenderivat.
FI873058A7 (fi) Foerfarande foer framstaellning av nya difosfonsyraderivat.
FI883056L (fi) Nya former av kolonistimulerande faktor-1.
FI851837A0 (fi) Foerfarande foer framstaellning av nya kompositioner.
FI865154A7 (fi) Nya katalysatorsystem foer framstaellning av isocyanurat- och uretanbindningar innehaollande skum.
FI862519A7 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara kinolonderivat.
FI871445A7 (fi) Foerfarande foer framstaellning av nya spergualinderivat.
FI882121A7 (fi) Nya 4-bensyl-1-(2h) -ftalazinonderivat innehaollande en aminosyrarest.
FI854298L (fi) Framstaellningsfoerfarande av nya tienopyridinderivat.
FI862400L (fi) Foerfarande foer framstaellning av nya isatinkompositioner.
FI861681A0 (fi) Foerfarande foer framstaellning av nya 4-fenylpropyl-indolderivat.
FI864893A0 (fi) Foerfarande foer framstaellning av nya tetrahydroisokinolinderivat.
FI862174A7 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara berbanderivat.
FI882020A7 (fi) Nya 2-aminoalkyl-4-benzyl-1-(2h)-ftalazinonderivat.
FI854088A0 (fi) Foerfarande foer framstaellning av nya pyridinderivat.
FI862566A7 (fi) Foerfarande foer framstaellning av nya penemderivat.
FI862184A7 (fi) Foerfarande foer framstaellning av nya fenolderivat.
FI853535L (fi) Foerfarande foer framstaellning av nya bensazolderivat.
FI863398A7 (fi) Foerfarande foer framstaellning av nya hydropyridinderivat.
FI863743A0 (fi) Framstaellningsfoerfarande av nya bicykliska catecolderivat.
FI861414A7 (fi) Foerfarande foer framstaellning av nya bensoesyraderivat.
FI872527L (fi) Foerfarande foer framstaellning av nya peptider.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: ASTA MEDICA AKTIENGESELLSCHAFT